BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cardamonin

2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone [Supplementary Concept] has antineoplastic activity; blocks NF-kappaB p65 activation; structure in first source; do not confuse with DMC cpd Heading Mapped to: Chalcones

180+ PubMed studies analyzed · Evidence Score: 37

Research Domains

Cardamonin has been studied across 20 research domains including 🔬 Oncology, 🔬 Inflammation, 🏋️ Muscle & Hypertrophy, 🛡️ Immunity, 🧘 Stress & Anxiety. The primary research focus is 🔬 Oncology with 48% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cardamonin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Anisomycin
9 shared targets
sar
2 shared targets
bdb
2 shared targets
hinokiflavone
2 shared targets
Strophanthidin
7 shared targets
nutlin
2 shared targets
Tubercidin
6 shared targets
colchine
3 shared targets
Dinitrochlorobenzene
6 shared targets
Digoxigenin
6 shared targets
Loading evidence profile...

This evidence profile for Cardamonin is generated deterministically from 180 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.